Skip to content

Study · Non-randomized trial · 2012

3 results

[The use of Timalin in the treatment of the acute lung abscess].

Tsybikov MN, Likhanov ID, Borshchevskiĭ VS, Kuznik BI, Tsepelev VL, Maslo EIu, Tsybikov NN

Khirurgiia1 Jan 2012Cited by 1 (Europe PMC)

PMID23258355 (opens in a new tab)PepBankPUB-23258355
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with acute lung abscess, added Timalin accelerated normalization of SIRS indicators compared with traditional treatment.

    In plain wordsIn patients with lung abscess, added Timalin normalized inflammation indicators faster than traditional treatment.

    Peptide
    Thymalin
    Outcome
    IncreaseSIRS indicator normalization
    Study

    n: not reported in source

    Comparator
    Traditional treatment
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The study demonstrated that induction of bioregulative therapy leads to faster normalization of main indicators of SIRS and plasma fibrinolitic activity and eliminates hypercoagulation.
    1 context sentence
    Summary · context
    The study was aimed to research levels of main acute inflammation phase peptides, coagulative and fibrinolitic plasma activity on the background of traditional treatment and with addition of Timalin in patients with acute lung abscess.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with acute lung abscess, added Timalin accelerated normalization of plasma fibrinolytic activity compared with traditional treatment.

    In plain wordsIn patients with lung abscess, added Timalin normalized clot breakdown activity faster than traditional treatment.

    Peptide
    Thymalin
    Outcome
    IncreasePlasma fibrinolytic activity normalization
    Study

    n: not reported in source

    Comparator
    Traditional treatment
    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The study demonstrated that induction of bioregulative therapy leads to faster normalization of main indicators of SIRS and plasma fibrinolitic activity and eliminates hypercoagulation.
    1 context sentence
    Summary · context
    The study was aimed to research levels of main acute inflammation phase peptides, coagulative and fibrinolitic plasma activity on the background of traditional treatment and with addition of Timalin in patients with acute lung abscess.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with acute lung abscess, therapy with Timalin added to traditional treatment eliminated hypercoagulation.

    In plain wordsIn patients with lung abscess, adding Timalin to traditional treatment eliminated excessive clotting.

    Peptide
    Thymalin
    Outcome
    DecreaseHypercoagulation
    Study

    n: not reported in source

    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The study demonstrated that induction of bioregulative therapy leads to faster normalization of main indicators of SIRS and plasma fibrinolitic activity and eliminates hypercoagulation.
    1 context sentence
    Summary · context
    The study was aimed to research levels of main acute inflammation phase peptides, coagulative and fibrinolitic plasma activity on the background of traditional treatment and with addition of Timalin in patients with acute lung abscess.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.